Biotech Showcase investor and partnering conference returns to In a release,
This established innovation showcase for life science investors will be held
Biotech Showcase, Streetwise Reports, and
A closing reception and panel entitled "The Last Word" with The Life Sciences Report, RMI and BioPharm Insight will be held on Wednesday evening. This lively, and potentially irreverent, discussion will be moderated by
This year's program features three lunch plenary topics with well- known industry thought leaders.
"The return of optimism in the IPO market is good news, but we should always have multiple paths to maximize any one option, and we should continue to embrace innovative financing and partnering models as viable and lucrative alternatives," said Hastings, who, besides his role as Chairman and CEO of OncoMed, is a well-known biotech industry advocate and chairman of the
Tuesday's lunch plenary is moderated by
"Understanding the patient is the key to understanding the market," said Gopka. "This is not new. What is new is the degree to which patients influence drug development areas based on need, based on accessibility, based on results. I think most biotech companies have realized that their connection to the patients can benefit their commercialization strategy. This panel should be an interesting discussion on who influences whom."
The third lunch plenary will take place on Wednesday, and is entitled "How do you define value?" and will be moderated by
Other program highlights include business workshops on topics ranging from Parkinson's disease, cancer checkpoints, molecular diagnostics, big data and
Biotech Showcase is powered by partneringONE, the industry's most advanced partnering system that enables delegates to efficiently identify and arrange meetings with potential investors and partners.
Biotech Showcase is an investor and partnering conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.
The 2013 edition showed a substantial increase in the number of presenting companies, as well as significant growth in the number of attendees and one-to-one meetings. The 2013 event featured corporate presentations by 236 public and private biotechnology and life science companies, and drew 1,600 delegates who engaged in 2,500 one- to-one meetings.
((Comments on this story may be sent to firstname.lastname@example.org))
Biotech Showcase investor and partnering conference returns to
In a release,